{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:07:03Z","timestamp":1750421223147},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T00:00:00Z","timestamp":1366934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12020-013-9959-1","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T21:37:37Z","timestamp":1367357857000},"page":"221-229","source":"Crossref","is-referenced-by-count":9,"title":["Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre"],"prefix":"10.1007","volume":"45","author":[{"given":"M.","family":"Giusti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Caorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mortara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Bagnara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Minuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,26]]},"reference":[{"key":"9959_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0016","volume":"24","author":"L Hegedus","year":"2003","unstructured":"L. Hegedus, S.J. Bonnema, F.N. Bennedback, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24, 102\u2013132 (2003). doi: 10.1210\/er.2002-0016","journal-title":"Endocr. Rev."},{"key":"9959_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MED.0b013e32832ff2e1","volume":"16","author":"SJ Bonnema","year":"2009","unstructured":"S.J. Bonnema, L. Hegedus, A 30-year perspective on radioiodine therapy of benignant non-toxic multinodular goiter. Curr. Opin. Endocrinol. Diabetes Obes. 16, 379\u2013384 (2009). doi: 10.1097\/MED.0b013e32832ff2e1","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"9959_CR3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jc.2011-1162","volume":"97","author":"RH Grogan","year":"2012","unstructured":"R.H. Grogan, E.J. Mitmaker, J. Hwang, J.E. Gosnell, Q.-Y. Duh, O.H. Clark, W.T. Shen, A population-based prospective cohort study of complication after thyroidectomy in the elderly. J. Clin. Endocrinol. Metab. 97, 1645\u20131653 (2012). doi: 10.1210\/jc.2011-1162","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR4","first-page":"3638","volume":"84","author":"SJ Bonnema","year":"1999","unstructured":"S.J. Bonnema, H. Bertelsen, J. Mortensen, P.B. Andersen, D.U. Knudsen, L. Bastholt, L. Hegedus, The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect of thyroid function and size and pulmonary function. J. Clin. Endocrinol. Metab. 84, 3638\u20133641 (1999). doi: 10.1210\/jc.84.10.3636","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1997.7.235","volume":"7","author":"D Huysmans","year":"1997","unstructured":"D. Huysmans, A. Hermus, M. Edelbroek, J. Barentsz, F. Corstens, P. Kloppenborg, Radioiodine for non-toxic multinodular goiter. Thyroid 7, 235\u2013239 (1997)","journal-title":"Thyroid"},{"key":"9959_CR6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bmj.307.6908.828","volume":"307","author":"B Nygaard","year":"1993","unstructured":"B. Nygaard, L. Hegedus, M. Gervil, H. Hjalgrim, P. Soe-Jensen, J.M. Hansen, Radioiodine treatment of multinodular non-toxic goitre. BMJ 307, 828\u2013832 (1993). doi: 10.1136\/bmj.307.6908.828","journal-title":"BMJ"},{"key":"9959_CR7","first-page":"3592","volume":"85","author":"DA Huysmans","year":"2000","unstructured":"D.A. Huysmans, W.A. Nieuwlaat, R.J. Erdtsieck, A.P. Schellekens, J.W. Bus, B. Bravenboer, A.R. Hermus, Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxix nodular goiter. J. Clin. Endocrinol. Metab. 85, 3592\u20133596 (2000). doi: 10.1210\/jc.85.10.3592","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR8","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1210\/jcem.86.11.8014","volume":"86","author":"WA Nieuwlaat","year":"2001","unstructured":"W.A. Nieuwlaat, A.R. Hermus, F. Sicro-Prndelj, F.H. Corstens, D.A. Huysmans, Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J. Clin. Endocrinol. Metab. 86, 5330\u20135336 (2001). doi: 10.1210\/jc.86.11.5330","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR9","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2002-021554","volume":"88","author":"WA Nieuwlaat","year":"2003","unstructured":"W.A. Nieuwlaat, D.A. Huysmans, H.C. Van den Bosch, G.C. Sweep, H.A. Ross, F.H. Corstens, A.R. Hermus, Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J. Clin. Endocrinol. Metab. 88, 3121\u20133129 (2003). doi: 10.1210\/jc.2002-021554","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR10","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/jc.2004-0458","volume":"90","author":"CC Albino","year":"2005","unstructured":"C.C. Albino, C.O. Mesa Jr, M. Olandoski, C.E. Ueda, L.C. Woellner, C.A. Goedert, A.M. Souza, H. Graf, Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J. Clin. Endocrinol. Metab. 90, 2775\u20132780 (2005). doi: 10.1210\/jc.2004-0458","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S0100-879X2010007500001","volume":"43","author":"CC Albino","year":"2010","unstructured":"C.C. Albino, H. Graf, G. Paz-Filho, L.A. Diehl, M. Olandoski, A. Sabbag, C. Buchpiguel, Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter. Braz. J. Med. Biol. Res. 43, 303\u2013309 (2010)","journal-title":"Braz. J. Med. Biol. Res."},{"key":"9959_CR12","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1210\/jc.2007-0501","volume":"92","author":"SJ Bonnema","year":"2007","unstructured":"S.J. Bonnema, V.E. Nielsen, H. Boel-Jorgensen, P. Gruppe, P.B. Anderson, L. Bastholt, L. Hegedus, Improvement of goiter volume reduction after 0.3\u00a0mg recombinant human thyrotorpin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomised trail. J. Clin. Endocrinol. Metab. 92, 3424\u20133428 (2007). doi: 10.1210\/jc.2007-0501","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/eje.1.02094","volume":"154","author":"O Cohen","year":"2006","unstructured":"O. Cohen, J. Ilany, C. Hoffman, D. Olchovsky, S. Dabhi, A. Karasik, E. Goshen, G. Rotenberg, S.T. Zwas, Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur. J. Endocrinol. 154, 243\u2013252 (2006). doi: 10.1530\/eje.1.02094","journal-title":"Eur. J. Endocrinol."},{"key":"9959_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1742-1241.2008.01904.x","volume":"63","author":"ER Cubas","year":"2009","unstructured":"E.R. Cubas, G.J. Paz-Filho, M. Olandoski, C.A. Goedert, L.C. Woellner, G.A. Carvalho, H. Graf, Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre. Int. J. Clin. Pract. 63, 583\u2013590 (2009). doi: 10.1111\/j.1742-1241.2008.01904.x","journal-title":"Int. J. Clin. Pract."},{"key":"9959_CR15","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1210\/jc.2010-0634","volume":"95","author":"S Fast","year":"2010","unstructured":"S. Fast, L. Hegedus, P. Grupe, V.E. Nielsen, C. Bluhme, L. Bastholt, S.J. Bonnema, Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J. Clin. Endocrinol. Metab. 95, 3719\u20133725 (2010). doi: 10.1210\/jc.2010-0634","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR16","first-page":"191","volume":"31","author":"M Giusti","year":"2006","unstructured":"M. Giusti, C. Cappi, B. Santaniello, E. Ceresola, C. Augeri, C. Lagasio, F. Minuto, Safety and efficacy of administering 0.2\u00a0mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large multinodular goiter. Minerva Endocrinol. 31, 191\u2013209 (2006)","journal-title":"Minerva Endocrinol."},{"key":"9959_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-6614-2-6","volume":"2","author":"M Giusti","year":"2009","unstructured":"M. Giusti, M. Caputo, I. Calamia, M.C. Bagnara, E. Ceresola, M. Schiavo, M. Mussap, D. Ferone, F. Minuto, M. Bagnasco, Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. Thyroid Res. 2, 6 (2009). doi: 10.1186\/1756-6614-2-6","journal-title":"Thyroid Res."},{"key":"9959_CR18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archinte.166.14.1476","volume":"166","author":"VE Nielsen","year":"2006","unstructured":"V.E. Nielsen, S.J. Bonnema, H. Boel-Jorgensen, P. Gruppe, L. Hegedus, Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic goiter: a prospective randomised double-blind trial. Arch. Intern. Med. 166, 1476\u20131482 (2006). doi: 10.1001\/archint.166.14.1476","journal-title":"Arch. Intern. Med."},{"key":"9959_CR19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1590\/S0100-879X2006005000186","volume":"40","author":"GJ Paz-Filho","year":"2007","unstructured":"G.J. Paz-Filho, C.O. Mesa-Junior, M. Olandoski, L.C. Woellner, C.A. Goedert, C.L. Boguszewski, G.A. Carvalho, H. Graf, Effect of 30\u00a0mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz. J. Med. Biol. Res. 40, 1661\u20131670 (2007)","journal-title":"Braz. J. Med. Biol. Res."},{"key":"9959_CR20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/thy.2008.0394","volume":"19","author":"R Romao","year":"2009","unstructured":"R. Romao, I.G.S. Rubio, E.K. Tominori, Y. Camargo, M. Knobel, G. Medeiros-Neto, High prevalence of side effect after recombinant human thyrotropin-stimulated radioiodine treatment with 30\u00a0mCi in patients with multinodular goiter and subclinical\/clinical hyperthyroidism. Thyroid 19, 945\u2013951 (2009)","journal-title":"Thyroid"},{"key":"9959_CR21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2265.2003.01918.x","volume":"60","author":"MN Silva","year":"2004","unstructured":"M.N. Silva, I.G.S. Rubio, R. Romao, E.M.M.S. Gebrin, C. Buchpiguel, E. Tomimori, R. Camargo, M.S. Cardia, G. Medeiros-Neto, Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goiter. Clin. Endocrinol. (Oxf) 60, 300\u2013308 (2004). doi: 10.1046\/j.1365-2265.2003.01918.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9959_CR22","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/jc.2011-3335","volume":"97","author":"S Fast","year":"2012","unstructured":"S. Fast, V.E. Nielsen, P. Groupe, B. Boel-Jorgensen, L. Bastholt, P.B. Andersen, S.J. Bonnema, L. Hegedus, Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. J. Clin. Endocrinol. Metab. 97, 2653\u20132660 (2012). doi: 10.1210\/jc.2011-3335","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2265.2005.02419.x","volume":"64","author":"MS Cardia","year":"2006","unstructured":"M.S. Cardia, I.G. Rubio, G. Medeiros-Neto, Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH. Clin. Endocrinol. (Oxf) 64, 474 (2006). doi: 10.1111\/j.1365-2265.2005.02419.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9959_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.2007.03165.x","volume":"69","author":"GJ Paz-Filho","year":"2008","unstructured":"G.J. Paz-Filho, C.O. Mesa, G.A. Carvalho, C.A. Goedert, H. Graf, Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2\u00a0years. Clin. Endocrinol. (Oxf) 69, 345\u2013346 (2008). doi: 10.1111\/j.1365-2265.2007.03165.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9959_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1088\/0031-9155\/45\/1\/309","volume":"45","author":"AC Traino","year":"2000","unstructured":"A.C. Traino, F. Di Martino, M. Lazzeri, M.G. Stabia, Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves\u2019 hyperthyroidism. Phys. Med. Biol. 45, 121\u2013129 (2000). doi: 10.1088\/0031-9155\/45\/1\/309","journal-title":"Phys. Med. Biol."},{"key":"9959_CR26","first-page":"255","volume":"150","author":"WZ Billewicz","year":"1969","unstructured":"W.Z. Billewicz, R.S. Chapman, J. Crooks, M.E. Day, J. Gossage, E. Wayne, J.A. Young, Statistical methods applied to the diagnosis of hypothyroidism. Q. J. Med. 150, 255\u2013266 (1969)","journal-title":"Q. J. Med."},{"key":"9959_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1631\/jzus.B1000382","volume":"12","author":"M Giusti","year":"2011","unstructured":"M. Giusti, G. Melle, M. Fenocchio, L. Mortara, F. Cecoli, V. Caorsi, D. Ferone, F. Minuto, E. Rasore, Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma. J. Zehjiang Univ. Sci. B. 12, 163\u2013173 (2011). doi: 10.1631\/jzus.B.1000382","journal-title":"J. Zehjiang Univ. Sci. B."},{"key":"9959_CR28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/jc.2005-2137","volume":"91","author":"VE Nielsen","year":"2006","unstructured":"V.E. Nielsen, S.J. Bonnema, L. Hegedus, Transient goiter enlargement after administration of 0.3\u00a0mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J. Clin. Endocrinol. Metab. 91, 1317\u20131322 (2006). doi: 10.1210\/jc.2005-2137","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9959_CR29","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1210\/jc.2010-1193","volume":"96","author":"H Graf","year":"2011","unstructured":"H. Graf, S. Fast, F. Pacini, A. Pinchera, A. Leung, M. Vaisman, C. Reiners, J.L. Wemeau, D. Huysmans, W. Harper, A. Driedger, H. de Noemberg Souza, M.G. Castagna, L. Antonangeli, L. Braverman, R. Corbo, C. Duren, E. Proust-Lemoine, A. Edelbroek, C. Mariott, I. Rachinsky, P. Gruppe, T. Watt, J. Magner, L. Hegedus, Modified-Release Recombinant Human TSH (MRrhTSH) augments the effect of \u00b9\u00b3\u00b9I therapy in benign multinodular goiter; results from a multicenter international, randomized, placebo-controlled study. J. Clin. Endocrinol. Metab. 96, 1368\u20131376 (2011). doi: 10.1210\/jc.2010-1193","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"9959_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00520-003-0474-4","volume":"11","author":"R Crevenna","year":"2003","unstructured":"R. Crevenna, G. Zetting, M. Keilani, M. Posch, M. Schmidinger, C. Pirich, M. Nuhr, M. Wolzt, M. Quittan, V. Fialka-Moser, Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Center 11(9), 597\u2013603 (2003). doi: 10.1007\/s00520-003-0474-4","journal-title":"Support Care Center"},{"key":"9959_CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/thy.2009.0187","volume":"20","author":"J Lee","year":"2010","unstructured":"J. Lee, M.J. Yun, K.H. Nam, W.Y. Choung, E.Y. Soh, C.S. Park, Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma. Thyroid 20, 173\u2013179 (2010)","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-9959-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9959-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T22:03:24Z","timestamp":1715292204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-9959-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,26]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9959"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-9959-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,26]]}}}